Table 8 Other FDA-approved anti-cancer therapies at the time of study but not used in the studied population
From: Off-label use of cancer therapies in women diagnosed with breast cancer in the United States
Category | Drug name |
|---|---|
Chemotherapies | Altretamine, Asparaginase, Bendamustine, Busulfan, Decitabine, Estramustine, Floxuridine, Liposomal Cytarabine, Lomustine, Nelarabine, Pegaspargase, Pentostatin, Procarbazine, Temozolomide, Teniposide, Thioguanine, Valrubicin |
Hormone therapies | Bicalutamide, Degarelix, Flutamide, Histrelin, Nilutamide, Toremifene, Triptorelin |
Targeted therapies | Dasatinib, Everolimus, Lapatinib, Nilotinib, Sorafenib, Temsirolimus, Vironostat. Bexarotene, Tretinoin |
Immunotherapies | BCG, Ibritumomab, Imiquimod, Interferon alfa-2a, Lenalidomide, Tositumomab |